AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Explore how Sp 500 stacks up against the Total Stock Market for retirement investing, focusing on long-term growth, volatility, and portfolio diversification.
28,492 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
As of mid-February 2026, state regulators hold a steady advantage in the legal battle over prediction markets, even w...
Standard Chartered projects stablecoins could generate up to $1 trillion of new US Treasury demand by 2028, signaling...
Rocket Companies closed 2025 with $6.7 billion in revenue and rising mortgage activity, alongside strategic deals tha...
A mid-February 2026 SEC filing shows Bank Hapoalim taking a new position in the FTCS ETF, worth about $14.7 million. ...
Outpoll launches a global prediction market platform, bringing professional tools and API access to a mainstream audi...
Former BitMEX CEO Arthur Hayes appears to be adding more ETH as critics circle over recent token hype and sales. Look...
Lineage and Rexford Industrial Realty offer starkly different paths in industrial real estate. This guide breaks down...
Investors are watching flutter (flut) 2026 earnings closely as FanDuel scales in the US and international markets. Th...
A fresh wave of AI-driven momentum is reshaping Amazon's outlook, and investors are paying close attention. This arti...
Block is pushing a bold crypto-backed play inside its fintech ecosystem. This article breaks down what the move could...
A new collaboration blends AI agents, stablecoins, and cloud services. Learn how amazon teams with coinbase and Strip...